The Synthesis of Glutamine-Functionalized Block Polymer and Its Application in Triple-Negative Breast Cancer Treatment
Open Access
- 26 May 2020
- journal article
- research article
- Published by Wiley in Journal of Nanomaterials
- Vol. 2020, 1-13
Abstract
Triple-negative breast cancer (TNBC) is a highly malignant tumor. At present, there are still no targeted drugs for TNBC. Clinical chemotherapeutic drugs, such as doxorubicin (DOX), have the characteristic of nontargeted distribution in treatment of TNBC, causing severe side effects. Therefore, new target treatment strategies for TNBC are of urgent need. It was speculated that glutamine could be a potential target because it is in high demand by TNBC. In this study, we found that the transporter for glutamine, ASCT2 (solute carrier family 1 member 5 (SLC1A5)), is highly expressed in TNBC by analysis of data from The Cancer Genome Atlas (TCGA) and experiments in vitro. Based on this, glutamine was grafted onto a polymeric drug carrier in order to develop a tumor-targeting drug delivery system for treatment of TNBC. Firstly, pH-responsive glutamine-PEG5000-b-PAE10000 (Gln-PEG-b-PAE) copolymers were synthesized using Fmoc-PEG5000-b-PAE10000 (Fmoc-PEG-b-PAE) copolymers. Then, Gln-PEG-b-PAE@DOX micelles were prepared by loading DOX to Gln-PEG-b-PAE copolymer using a solvent casting technology. In vitro, Gln-PEG-b-PAE@DOX micelles exhibited pH-dependent micellization-decellularization behavior; namely, they can rapidly release DOX in acidic environment of pH 6.0 but release very slowly in physiological condition. Moreover, glutamine competition experiment showed that Gln-PEG-b-PAE@DOX micelles had the ability to target MDA-MB-231 cells. Compared to free DOX, Gln-PEG-b-PAE@DOX micelles had significantly greater cytotoxic effect and antiproliferative activity against MDA-MB-231 cells. In vivo, compared to free DOX and mPEG-b-PAE@DOX micelles, Gln-PEG-b-PAE@DOX micelles significantly inhibited tumor growth in tumor-bearing mice. Therefore, Gln-PEG-b-PAE@DOX micelles, as a tumor-targeting drug delivery system, may provide a new method for the treatment of TNBC.Keywords
Funding Information
- Basic Research Program of Jiangsu Province (BK20191080, BK20181086, 81901883, 81801827, 81872365)
- Basic Research Program of Jiangsu Province (BK20191080, BK20181086, 81901883, 81801827, 81872365)
- National Natural Science Foundation of China (BK20191080, BK20181086, 81901883, 81801827, 81872365)
- National Natural Science Foundation of China (BK20191080, BK20181086, 81901883, 81801827, 81872365)
- National Natural Science Foundation of China (BK20191080, BK20181086, 81901883, 81801827, 81872365)
This publication has 32 references indexed in Scilit:
- Host–Guest Interactions Initiated Supramolecular Chitosan Nanogels for Selective Intracellular Drug DeliveryACS Applied Materials & Interfaces, 2019
- Highly Biocompatible Chlorin e6-Loaded Chitosan Nanoparticles for Improved Photodynamic Cancer TherapyACS Applied Materials & Interfaces, 2018
- Development and optimization of a tumor targeting system based on microbial synthesized PHA biopolymers and PhaP mediated functional modificationApplied Microbiology and Biotechnology, 2018
- pH-Responsive prodrug nanoparticles based on a sodium alginate derivative for selective co-release of doxorubicin and curcumin into tumor cellsNanoscale, 2017
- Cationic Conjugated Polymer/Hyaluronan-Doxorubicin Complex for Sensitive Fluorescence Detection of Hyaluronidase and Tumor-Targeting Drug Delivery and ImagingACS Applied Materials & Interfaces, 2015
- Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapyEuropean Journal of Pharmaceutics and Biopharmaceutics, 2015
- Chemo Brain (Chemo Fog) as a Potential Side Effect of Doxorubicin Administration: Role of Cytokine-Induced, Oxidative/Nitrosative Stress in Cognitive Dysfunction2010
- Doxorubicin: The Good, the Bad and the Ugly EffectCurrent Medicinal Chemistry, 2009
- Significant enhancement of antitumor activity and bioavailability of intracellular pH-sensitive polymeric micelles by folate conjugationJournal of Controlled Release, 2006
- Preparation and Biological Characterization of Polymeric Micelle Drug Carriers with Intracellular pH-Triggered Drug Release Property: Tumor Permeability, Controlled Subcellular Drug Distribution, and Enhanced in Vivo Antitumor EfficacyBioconjugate Chemistry, 2004